• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ageing Res Rev . Immunosenescence and inflamm-ageing in COVID-19

tetano

Editor, Senior Moderator
Ageing Res Rev


. 2022 Dec 11;84:101818.
doi: 10.1016/j.arr.2022.101818. Online ahead of print.
Immunosenescence and inflamm-ageing in COVID-19


Mohammad Reza Zinatizadeh[SUP] 1 [/SUP], Peyman Kheirandish Zarandi[SUP] 1 [/SUP], Mohsen Ghiasi[SUP] 2 [/SUP], Hamid Kooshki[SUP] 3 [/SUP], Mozafar Mohammadi[SUP] 4 [/SUP], Jafar Amani[SUP] 5 [/SUP], Nima Rezaei[SUP] 6 [/SUP]



Affiliations

Abstract

The destructive effects of coronavirus disease 2019 (COVID-19) on the elderly and people with cardiovascular disease have been proven. New findings shed light on the role of aging pathways on life span and health age. New therapies that focus on aging-related pathways may positively impact the treatment of this acute respiratory infection. Using new therapies that boost the level of the immune system can support the elderly with co-morbidities against the acute form of COVID-19. This article discusses the effect of the aging immune system against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the pathways affecting this severity of infection.

Keywords: COVID-19; Immunosenescence; Inflamm-ageing; SARS-CoV-2.
 
Back
Top Bottom